Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Neural migration is a critical step during brain development that requires the interactions of cell-surface guidance receptors. Cancer cells often hijack these mechanisms to disseminate. Here, we reveal crystal structures of Uncoordinated-5 receptor D (Unc5D) in complex with morphogen receptor glypican-3 (GPC3), forming an octameric glycoprotein complex. In the complex, four Unc5D molecules pack into an antiparallel bundle, flanked by four GPC3 molecules. Central glycan-glycan interactions are formed by N-linked glycans emanating from GPC3 (N241 in human) and C-mannosylated tryptophans of the Unc5D thrombospondin-like domains. MD simulations, mass spectrometry and structure-based mutants validate the crystallographic data. Anti-GPC3 nanobodies enhance or weaken Unc5-GPC3 binding and, together with mutant proteins, show that Unc5/GPC3 guide migrating pyramidal neurons in the mouse cortex, and cancer cells in an embryonic xenograft neuroblastoma model. The results demonstrate a conserved structural mechanism of cell guidance, where finely balanced Unc5-GPC3 interactions regulate cell migration.

Original publication

DOI

10.1016/j.cell.2022.09.025

Type

Journal article

Journal

Cell

Publication Date

13/10/2022

Volume

185

Pages

3931 - 3949.e26

Keywords

GPC3, UNC5A, UNC5B, UNC5C, UNC5D, Unc5, cell guidance, cell migration, cortex development, crystallography, glypican-3, nanobodies, neuroblastoma, stripe assay, structural biology, surface plasmon resonance, uncoordinated-5, Animals, Carcinoma, Hepatocellular, Cell Movement, Glypicans, Humans, Liver Neoplasms, Mice, Mutant Proteins, Receptors, Cell Surface, Single-Domain Antibodies, Thrombospondins